I'll prepare the research note now based on the filings.
B.P. MARSH & PARTNERS PLC (BPM) — Investment Research Note
Executive summary
B.P. Marsh & Partners is a specialist AIM-listed minority-stake private equity investor in early-stage insurance distribution businesses (brokers and Managing General Agencies) globally, with a 35-year track record of identifying entrepreneurial management teams and crystallising value through trade sales. NAV has compounded at 11.1% p.a. since the 2006 IPO and accelerated dramatically — from £166.6m at Jan-2022 to £349.5m at Jul-2025 — driven by five major realisations (Kentro, Paladin/CBC, Lilley Plummer Risks, SSRU, Sterling) at large premia to carrying values, all of which validate the conservatism of the NAV. The single most important valuation fact today is that the £241.7m market cap implies a ~31% discount to the 31 July 2025 undiluted NAV of 956.1p per share — a wide discount that has been only partially closed despite a sustained pattern of management-led exits delivering double-digit and in some cases >85% IRRs.
Fair value estimate
Methodology: Discount-to-NAV approach, anchored on the most recent disclosed NAV of £349.5m (956.1p undiluted; 909.8p fully diluted) at 31 July 2025 2025-10 half-year. Several recent realisations occurred at or above carrying value (Paladin +38% vs Jul-23 carry; LPR +26% vs Jul-24 carry; Kentro at carry; Sterling at carry; SSRU at substantial premium), giving confidence the reported NAV is realisable and not aggressive.
- Fair-value range: 815p – 955p per share
- Low (15% discount to diluted NAV of 909.8p): ~775p
- Mid (8% discount to diluted NAV): ~837p
- High (at undiluted NAV of 956.1p): ~955p
- Implied market-cap range: £283m – £349m (mid ~£305m)
- vs current £241.7m mcap: absolute upside of ~17% to ~45%, mid case ~27%
- A typical AIM specialist-investor discount-to-NAV is 10–20%, but BPM's track record of consistent NAV growth and crystallisation supports the tighter end. Applying a NAV-at-par exit for a control sale is not unreasonable given the demonstrated multi-decade NAV compounding.
Sector context
- ICB classification confirmed: Financials / Financial Services.
- Quality profile is above typical sector peers on net-cash balance sheet (debt-free since flotation), track record (11.1% annual NAV CAGR), and disclosure (transparent fair-value bridge, EBITDA multiples disclosed).
- Listed peers: closest analogues are AIM-listed specialist financial-services investors (e.g. Tavistock Investments, Litigation Capital Management) and Lloyd's-aligned insurance investors. There is no perfect listed peer; portfolio companies sit alongside private peers like Howden, Ardonagh (which was itself a former shareholder), and Specialist Risk Group (a buyer of CBC).
Investment thesis
Material discount to a NAV that has been repeatedly proven realisable. Five disposals since 2023 — Kentro at carry, Paladin at 38% premium, LPR at 26% premium, Sterling at carry, SSRU at substantial premium — demonstrate that the 956.1p NAV/share is conservative rather than aggressive 2025-02 trading update, 2025-10 half-year, 2026-02 trading update. Current 31% discount offers a margin of safety.
Strong cash recycling and accelerating shareholder returns. £28m of dividends payable across FY26–FY28 (~8% of Jul-2025 NAV), plus £6.9m of buy-backs since 2023 2026-04 deferred consideration & special dividend. Capital allocation discipline is improving — historical aspiration to "cover expenses from yield" plus recent excess-realisation distributions.
High-quality, diversified specialist insurance portfolio in a buoyant M&A market. The portfolio's two largest holdings — Pantheon Specialty (£105m / 30% of NAV at Jul-25) and XPT Group (£61m) — are both compounding revenues at 30–80% p.a. Insurance distribution M&A remains very active, providing exit optionality, and the £1.7bn aggregate GWP across the portfolio gives scale 2025-10 half-year.
Key risks
Softening insurance rates and growing commoditisation. Global rates fell 7% in H1-2025; soft-cycle pressure could reduce commission growth at investee MGAs/brokers, compressing the multiples on which NAV is calculated 2025-10 half-year market commentary. The post-discount weighted-average EBITDA multiple is already 13.2x — modest valuation compression on the unquoted book has direct NAV consequences.
Heavy concentration in two assets (Pantheon + XPT ≈ 48% of NAV). A reversal at either Pantheon (London casualty broker scaling from start-up in 2023 to a forecast £18m+ EBITDA in 2025) or XPT (US specialty platform with $1.2bn budgeted GWP) would materially impact NAV 2025-10 half-year.
Founder/concert-party concentration restricts share buy-backs and creates governance dependency. The Brian Marsh concert party holds ~42% of voting rights, capping the Company's ability to buy back stock without triggering a Rule 9 mandatory offer — historically constraining the principal mechanism for closing the NAV discount 2025-10 half-year, 2025-06 final results.
Operating leverage
BPM is structurally an asset-light holding company: H1-2026 operating expenses of £4.9m supported income of £36.1m and a fair-value gain of £30.8m — i.e. the central cost base is ~£10m/year against a portfolio yielding £8m+ in dividends/fees/loan interest plus capital growth. The Group "covers expenses from portfolio yield" as a stated policy, and underlying pre-tax (excluding revaluation) was only £0.7m H1-2026, reflecting that the BPM holding company has limited inherent operating leverage — incremental fee/dividend income mostly drops through but the absolute scale is small relative to capital gains. Operating leverage at the investee level is more meaningful: MGAs and brokers have largely fixed-cost-base economics where commission growth (driven by rates and new producer hires) drops disproportionately to EBITDA. Pantheon scaling from start-up to £18m EBITDA in 2.5 years is the clearest example. A 10–20% revenue beat across the portfolio at this stage of the cycle would likely add ~£20–35m to NAV (mid-teens % uplift), not multiples [inferred from 2025-10 half-year financials].
Value-trap signals
- Persistent discount to NAV despite a clean track record — partly explained by ~42% concert-party ownership reducing free float and the small AIM market cap.
- Level 3 valuations only — entire £271m equity book is unobservable inputs valued by directors. However, multiple recent realisations at or above carrying value materially mitigates this. Not a structural value-trap signal in BPM's case.
Earnings vs expectations
The Group does not give EPS guidance or operate to analyst-consensus EPS — its key metric is NAV per share, and against this it has consistently delivered or exceeded its own stated growth targets. Aggregate dividends have been increased each year since FY23 (£0.9m → £2m → £8m → £13m planned). Disposals have repeatedly exceeded the most recently published carry value (Paladin +38%, LPR +26%, SSRU substantial premium), and the SOP option plan's 10% CAGR NAV growth threshold was achieved by Jul-2024 2024-10 half-year, 2025-06 final results, 2026-02 trading update. Pattern: consistent meet-or-beat versus internal targets across the past three years.
Conviction: 4 / 5 — high
Conviction drivers:
- Multiple recent realisations at premia to carrying value provide independent validation of NAV.
- Long, transparent track record (11.1% annual NAV compound since flotation; 13.1% since 1990).
- Net-cash balance sheet and diversified portfolio limit downside.
Conviction caveats:
- Level 3 valuations remain a structural uncertainty; cycle softening could compress multiples.
- Two assets (Pantheon + XPT) drive nearly half the NAV — concentration risk.
Why this is a LOW fit for the investor's strategy (despite high conviction in fair value)
The investor's three explicit preferences are AI-receiver exposure, valuation discipline, and operating leverage. BPM scores strongly on valuation discipline but very poorly on AI exposure and only weakly on operating leverage. There is no AI-receiver angle in the portfolio — these are specialist insurance brokers, underwriting agencies, and one IFA. Even the Pantheon investment in Fraction (digital-asset insurance) is reinsurance for crypto, not AI infrastructure. Therefore, despite a clear ~25–30% upside to fair value and a quality balance sheet, BPM does not fit the investor's stated AI thesis and warrants a low overall score.